Wellcome Leap program – VISIBLE: Women’s heart disease revealed – Abstract

Well-being, Health and Biomedical Discovery

Deadlines

Academic Unit: Inquire with unit

Memorial Deadline: RIS Review not required for abstract

External Deadline: Monday 9th, March 2026


Description

Wellcome Leap is soliciting abstracts and proposals for work over three (3) years in one or more of the following thrust areas (see Thrust areas in full program announcement). Proposers should clearly relate work in these thrust areas to one or more of the program goals.

Thrust 1: Develop scalable approaches for diagnosis and monitoring of coronary microvascular disease.

Thrust 2: Identify risk factors and evaluate prognosis of coronary microvascular disease endotypes.

Thrust 3: Build and validate multiscale human-relevant models of the coronary microvasculature to interrogate causal mechanisms of coronary microvascular disease.

Thrust 4: Develop treatment strategies that improve both coronary microvascular function and patient-centered outcomes.

It is not necessary to form a large consortium or teams to address all facets of the program. The strength of this approach will manifest through program-level integration of efforts from individuals and small agile teams with deep (and sometimes narrow) expertise. Across all projects, Wellcome Leap will facilitate iterative and collaborative integration of findings to refine models and improve and validate predictive measures and adapt approaches as teams make progress towards shared goals.

Abstract Submission deadline: 9 March 2026 @ 11:59pm ET

Full proposal Submission deadline: 23 April 2026 @ 11:59pm ET

See here for more information.


Funding Sources

Wellcome Fund



This opportunity was posted by: RGCS

Last modified: February 24, 2026